rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Mary Teresa Shoemaker

Director

Company insider

Files Form 4 as: Director, Traws Pharma.

In numbers

Trades disclosed
14
Buys
2
Sells
0
Bought
$23K
Sold
$0
Companies
1
Companies where not an officer
1
First trade
9 Jul 2020
Last trade
9 Jul 2026
Last filed
14 Jul 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
TRAW Traws PharmaDirector · Biotechnology · last 9 Jul 20262 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
9 Jul 2026filed 14 Jul 2026TRAW Traws Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—14,150 at $0.00filing
9 Jul 2026filed 14 Jul 2026TRAW Traws Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—14,150 at $0.00filing
8 Mar 2026filed 10 Mar 2026TRAW Traws Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—33,435 at $0.00filing
8 Mar 2026filed 10 Mar 2026TRAW Traws Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—33,435 at $0.00filing
12 Dec 2025filed 16 Dec 2025TRAW Traws Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—24,629 at $0.00filing
12 Dec 2025filed 16 Dec 2025TRAW Traws PharmaBiotechnologySEC FORM 4 Code A—6,157 at $0.00filing
12 Oct 2025filed 15 Oct 2025TRAW Traws Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—11,530 at $0.00filing
19 Jun 2025filed 23 Jun 2025TRAW Traws Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—23,000 at $0.00filing
10 Aug 2023filed 14 Aug 2023TRAW Traws Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—66,468 at $0.00filing
18 Aug 2022filed 19 Aug 2022TRAW Traws Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—66,468 at $0.00filing
30 Jul 2021filed 30 Jul 2021TRAW Traws Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—13,000 at $0.00filing
16 Feb 2021filed 17 Feb 2021TRAW Traws PharmaBiotechnologySEC FORM 4 Bought$13K13,000 at $1.00filing
25 Nov 2020filed 30 Nov 2020TRAW Traws PharmaBiotechnologySEC FORM 4 Bought$10K37,735 at $0.27filing
9 Jul 2020filed 10 Jul 2020TRAW Traws Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—125,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

Charles David PauzaChief Science Officer Virology · Chief Science Officer Virology at Traws Pharma, filing Form 4 there in the last year
Werner CautreelsDirector · Director at Traws Pharma, filing Form 4 there in the last year
Nikolay SavchukChief Operating Officer · Chief Operating Officer at Traws Pharma, filing Form 4 there in the last year
Robert RedfieldChief Medical Officer · Chief Medical Officer at Traws Pharma, filing Form 4 there in the last year
Jack E. StoverChief Executive Officer · Director at Traws Pharma, filing Form 4 there in the last year